Abbott Laboratories logo

Abbott Laboratories (ABT)

Market Closed
5 Dec, 20:00
NYSE NYSE
$
125. 08
-0.32
-0.26%
$
223.73B Market Cap
36.49 P/E Ratio
2.2% Div Yield
3,295,006 Volume
4.44 Eps
$ 125.4
Previous Close
Day Range
124.64 126.05
Year Range
110.86 141.23
Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 45 days
Here's Why Abbott (ABT) Fell More Than Broader Market

Here's Why Abbott (ABT) Fell More Than Broader Market

Abbott (ABT) closed the most recent trading day at $113.70, moving -0.39% from the previous trading session.

Zacks | 1 year ago
Abbott Stock Hurt by Macroeconomic Issues & FX Headwind

Abbott Stock Hurt by Macroeconomic Issues & FX Headwind

Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the United States.

Zacks | 1 year ago
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga | 1 year ago
Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns

Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns

Dividend stocks are all-weather investments for buy-and-hold investing because they can help reduce portfolio volatility while generating income. Buying them when they are down and building a solid position is the recipe for market-beating total returns over time.

Marketbeat | 1 year ago
Abbott (ABT) Rises Higher Than Market: Key Facts

Abbott (ABT) Rises Higher Than Market: Key Facts

Abbott (ABT) reachead $117.63 at the closing of the latest trading day, reflecting a +1.06% change compared to its last close.

Zacks | 1 year ago
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Zacks | 1 year ago
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?

Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run.

Fool | 1 year ago
Abbott's Still Crushing It

Abbott's Still Crushing It

Abbott's diversified growth, driven by innovative medical devices and established pharmaceuticals, positions it well for long-term success and market outperformance. Despite legal challenges and post-pandemic headwinds, Abbott's robust earnings growth and solid dividend profile make it an attractive investment. Abbott's strong innovation pipeline, including advancements in CGM systems, supports its market share gains and growth outlook.

Seekingalpha | 1 year ago
3 Ultra-Safe Dividend Stocks for Retirees to Buy and Hold

3 Ultra-Safe Dividend Stocks for Retirees to Buy and Hold

Dividend stocks that grow their payouts can be ideal income sources for investors to buy and hold. The stocks listed here have profitable and predictable businesses, making them safe options to invest in.

Fool | 1 year ago
2 Stocks That Are Passive Income Machines to Buy and Hold Forever

2 Stocks That Are Passive Income Machines to Buy and Hold Forever

These two companies have been leaders in the healthcare industry for a long time. Both have solid underlying businesses and belong in the group of Dividend Kings.

Fool | 1 year ago
Why Abbott (ABT) Outpaced the Stock Market Today

Why Abbott (ABT) Outpaced the Stock Market Today

In the latest trading session, Abbott (ABT) closed at $117.11, marking a +0.58% move from the previous day.

Zacks | 1 year ago
Abbott's Lingo CGM System Gains U.S. Availability: Stock to Gain?

Abbott's Lingo CGM System Gains U.S. Availability: Stock to Gain?

ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who are not on insulin.

Zacks | 1 year ago
Loading...
Load More